comparemela.com

Latest Breaking News On - Stern investor - Page 8 : comparemela.com

Oncoinvent Initiates Radspherin® Phase 2A Trial

Inhibikase Therapeutics, Inc (IKT) CEO Milton Werner on Q2 2022 Results - Earnings Call Transcript

Akouos Reports Second Quarter 2022 Financial Results and Provides Business Highlights

15.08.2022 - Submitted IND for AK-OTOF to FDA Continued progress toward planned IND submission for AK-antiVEGF Presented new nonclinical data at ASGCT supporting the proposed clinical development of AK-OTOF and highlighting strategies for regulated gene .

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.